Transition Bio - Crunchbase Company Profile & Funding

Q: Who invested in Transition Bio?

Transition Bio has 5 investors including Bristol-Myers Squibb And Northpond Ventures.

Q: When was the last funding round for Transition Bio?

Transition Bio closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Transition Bio raised to date?

Transition Bio has raised obfuscated.

Overview

Transition Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Transition Bio

CB Rank

23482

Transition Bio provides condensate technology for drug discovery and diagnostics.

Founded

obfuscation

Private

Venture - Series Unknown

Cambridge, Massachusetts, United States

11-50

www.transitionbio.com/

Biotechnology

Health Care

Health Diagnostics

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Martin Kulander: Chief Operating Officer
Gregory Miller: Chief Executive Officer

Details

Legal Name

Transition Bio, Inc.

Operating Status

Active

Company Type

For Profit

Founders

David Weitz, Peter St George-Hyslop, Sarah Teichmann, Tuomas Knowles

About the Company

Transition Bio provides condensate technology for drug discovery and diagnostics. The company focuses on the discovery, analysis, and modulation of biological condensates, propelled by a differentiated technological capability that generates expansive drug development opportunities in a hypothesis-free manner.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Transition Bio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

PhaseScanTM

A microfluidics-based high throughput molecular screen used to identify drug candidates and their mechanisms of action.

CelPhaseTM

High-content cellular imaging technology for visualizing condensates in disease cell models and patient samples, aiding in target validation.

Research & Development

Transition Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Transition Bio	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Bristol-Myers Squibb	—	Series A - Transition Bio	—
Bristol-Myers Squibb	—	Series A - Transition Bio	—
Bristol-Myers Squibb	—	Series A - Transition Bio	—
Bristol-Myers Squibb	—	Series A - Transition Bio	—
Bristol-Myers Squibb	—	Series A - Transition Bio	—